Canadian Academy of Geriatric Psychiatry 2013 Annual Scientific Meeting Abstracts

Corinne E. Fischer

DOI: https://doi.org/10.5770/cgj.17.119

2013-03-05

Canadian Geriatrics Journal

Abstract:Background/Discussion: The DSM-5 was published in May 2013 after six years of literature reviews, input from experts, field trials, secondary data analyses, and public commentary. Changes were guided by clinical utility (e.g., decreasing diagnosis of over-inclusive diagnoses; drawing attention to underrecognized conditions; reducing stigma); research evidence; maintaining continuity with DSM-IV; and harmonization with ICD-11. The DSM-5 promotes a lifespan perspectives with chapters ordered based on when disorders manifest in life. Changes that impact older individuals include eliminating the 2-month wait before diagnosing a major depressive disorder following bereavement; listing hoarding disorder as a new disorder and persistent complex bereavement disorder as a condition requiring further study; classifying agoraphobia separately from panic disorder; and reorganizing the cognitive disorders, now called neurocognitive disorders (NCD). To decrease stigma, dementias and MCI are called major and mild NCD. Both are subtyped based on 13 probable or possible etiologies and associated with specifiers indicating behavioural disturbances (e.g., psychotic symptoms, mood disturbances, agitation, or apathy) and severity (i.e., functional dependence). The DSM-5 acknowledges that: boundaries between normal cognition, mild NCD, and major NCD are arbitrary; substantial decline in only one cognitive domain is needed to diagnose major NCD, making it broader than dementia; the importance of neuropsychological assessment; and the potential utility of biomarkers (e.g., genetics, neuroimaging).